Humana - HUM Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $602.44
Forecasted Upside: 21.31%
Number of Analysts: 15
Breakdown:
0 Sell Ratings
1 Hold Ratings
14 Buy Ratings
0 Strong Buy Ratings

^$496.60 As of 05/26/2023 01:00 AM ET

▼ -3.47 (-0.69%)

1 month | 3 months | 12 months

Get New Humana Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for HUM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HUM

^$602.44

▲ +21.31% Upside Potential

This price target is based on 15 analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $602.44, with a high forecast of $652.00 and a low forecast of $510.00. The average price target represents a 21.31% upside from the last price of $496.60.

Current Consensus is Buy

The current consensus among 15 investment analysts is to buy stock in Humana. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
14 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

12/4/2021

0 strong buy ratings
15 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

3/4/2022

0 strong buy ratings
15 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

6/2/2022

0 strong buy ratings
15 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

8/31/2022

0 strong buy ratings
12 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

11/29/2022

0 strong buy ratings
14 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

2/27/2023

0 strong buy ratings
15 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

4/28/2023

0 strong buy ratings
14 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

5/28/2023

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/27/2023	Deutsche Bank Aktiengesellschaft	Boost Target		$562.00 ➝ $568.00	Low
4/27/2023	SVB Securities	Lower Target		$640.00 ➝ $600.00	Low
4/20/2023	Cantor Fitzgerald	Initiated Coverage	Overweight	$597.00	Low
4/13/2023	Truist Financial	Boost Target	Hold	$560.00 ➝ $590.00	Low
4/11/2023	Morgan Stanley	Boost Target	Overweight	$620.00 ➝ $637.00	Low
2/28/2023	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$575.00 ➝ $562.00	Low
2/7/2023	Truist Financial	Lower Target	Hold	$580.00 ➝ $560.00	Low
2/6/2023	Cowen	Lower Target	Outperform	$647.00 ➝ $581.00	Low
2/6/2023	Credit Suisse Group	Lower Target	Outperform	$635.00 ➝ $575.00	Low
2/3/2023	Stephens	Lower Target	Overweight	$625.00 ➝ $590.00	Low
2/2/2023	UBS Group	Lower Target	Buy	$645.00 ➝ $620.00	Low
1/6/2023	JPMorgan Chase & Co.	Lower Target	Overweight	$630.00 ➝ $625.00	Low
12/13/2022	The Goldman Sachs Group	Upgrade	Neutral ➝ Buy	$575.00 ➝ $652.00	Low
11/10/2022	Mizuho	Boost Target	Buy	$529.00 ➝ $615.00	Low
11/8/2022	Wells Fargo & Company	Boost Target		$558.00 ➝ $610.00	Low
11/7/2022	Cowen	Boost Target		$547.00 ➝ $647.00	Low
11/7/2022	Cowen	Boost Target		$547.00 ➝ $647.00	Low
11/3/2022	The Goldman Sachs Group	Boost Target	Neutral	$522.00 ➝ $575.00	Low
11/3/2022	SVB Leerink	Boost Target	Outperform	$540.00 ➝ $640.00	Low
11/3/2022	Truist Financial	Boost Target		$570.00 ➝ $650.00	Low
11/3/2022	Royal Bank of Canada	Boost Target	Outperform	$560.00 ➝ $637.00	Low
11/3/2022	Credit Suisse Group	Boost Target	Outperform	$548.00 ➝ $635.00	Low
10/31/2022	Morgan Stanley	Boost Target	Overweight	$549.00 ➝ $620.00	Low
10/26/2022	Deutsche Bank Aktiengesellschaft	Upgrade	Hold ➝ Buy	$514.00 ➝ $576.00	Low
9/20/2022	Royal Bank of Canada	Boost Target	Outperform	$541.00 ➝ $544.00	Low
9/20/2022	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$494.00 ➝ $549.00	Low
9/16/2022	Truist Financial	Boost Target	Hold	$550.00 ➝ $570.00	Low
9/16/2022	Oppenheimer	Boost Target	Outperform	$520.00 ➝ $550.00	Low
8/9/2022	Cowen	Boost Target		$547.00	Low
8/2/2022	Morgan Stanley	Boost Target	Equal Weight	$453.00 ➝ $494.00	Low
7/28/2022	SVB Leerink	Boost Target	Outperform	$535.00 ➝ $540.00	Low
7/28/2022	Deutsche Bank Aktiengesellschaft	Boost Target		$450.00 ➝ $514.00	Low
7/28/2022	Oppenheimer	Boost Target	Outperform	$510.00 ➝ $520.00	Low
7/19/2022	Credit Suisse Group	Set Target		$548.00	Low
7/14/2022	Truist Financial	Boost Target	Hold	$490.00 ➝ $550.00	Low
6/16/2022	Loop Capital	Initiated Coverage	Buy	$510.00	Medium
5/26/2022	Sanford C. Bernstein	Initiated Coverage	Market Perform	$480.00 ➝ $506.00	Medium
5/25/2022	Wells Fargo & Company	Boost Target	Overweight	$512.00 ➝ $514.00	Low
4/28/2022	Wells Fargo & Company	Boost Target		$491.00 ➝ $512.00	High
4/13/2022	UBS Group	Upgrade	Neutral ➝ Buy	$486.00 ➝ $520.00	Medium
4/7/2022	Truist Financial	Boost Target		$460.00 ➝ $490.00	High
3/9/2022	Morgan Stanley	Boost Target	Equal Weight	$410.00 ➝ $436.00	Low
2/3/2022	Deutsche Bank Aktiengesellschaft	Boost Target		$418.00 ➝ $435.00	Medium
2/3/2022	SVB Leerink	Lower Target	Outperform	$528.00 ➝ $525.00	Medium
1/11/2022	Sanford C. Bernstein	Lower Target		$470.00 ➝ $431.00	Low
1/7/2022	Mizuho	Reiterated Rating	Buy	$500.00	High
1/7/2022	UBS Group	Reiterated Rating	Hold	$486.00	High
1/7/2022	BMO Capital Markets	Lower Target		$490.00 ➝ $415.00	Low
1/7/2022	Wells Fargo & Company	Lower Target		$529.00 ➝ $452.00	Low
1/7/2022	Deutsche Bank Aktiengesellschaft	Lower Target	Hold ➝ Hold	$476.00 ➝ $418.00	Low
1/7/2022	Morgan Stanley	Lower Target	Equal Weight	$530.00 ➝ $410.00	High
1/7/2022	Barclays	Lower Target	Overweight	$540.00 ➝ $490.00	High
1/6/2022	Wells Fargo & Company	Upgrade	Equal Weight ➝ Overweight	$492.00 ➝ $529.00	High
1/5/2022	Truist Financial	Boost Target	Hold ➝ Hold	$500.00 ➝ $520.00	Low
12/16/2021	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$559.00 ➝ $530.00	Low
12/14/2021	The Goldman Sachs Group	Initiated Coverage	Neutral	$472.00	High
11/10/2021	Mizuho	Boost Target	Buy	$480.00 ➝ $500.00	Low
11/9/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$427.00 ➝ $456.00	Low
11/9/2021	Citigroup	Boost Target	Buy	$510.00 ➝ $528.00	Low
11/4/2021	Bank of America	Boost Target	Buy	$505.00 ➝ $530.00	Low
11/4/2021	Morgan Stanley	Boost Target	Overweight	$513.00 ➝ $559.00	Low
11/4/2021	Oppenheimer	Boost Target	Outperform	$480.00 ➝ $510.00	Medium
11/4/2021	Credit Suisse Group	Boost Target	Outperform	$500.00 ➝ $513.00	Medium
11/4/2021	SVB Leerink	Boost Target	Outperform	$494.00 ➝ $528.00	Medium
11/4/2021	Royal Bank of Canada	Boost Target	Outperform	$479.00 ➝ $525.00	Medium
11/4/2021	Barclays	Boost Target	Overweight	$500.00 ➝ $540.00	Medium
9/27/2021	SVB Leerink	Initiated Coverage	Outperform	$494.00	Low
9/9/2021	Cowen	Initiated Coverage	Outperform	$479.00	High
9/9/2021	Barclays	Initiated Coverage	Overweight	$500.00	Low
8/31/2021	Morgan Stanley	Boost Target	Overweight	$500.00 ➝ $513.00	Low
7/9/2021	Seaport Res Ptn	Reiterated Rating	Neutral		Low
7/9/2021	JPMorgan Chase & Co.	Boost Target	Overweight	$440.00 ➝ $514.00	Low
5/24/2021	Wells Fargo & Company	Initiated Coverage	Equal Weight	$472.00	N/A
5/18/2021	Wells Fargo & Company	Initiated Coverage	Equal Weight	$472.00	Medium
4/29/2021	Citigroup	Boost Target		$496.00 ➝ $510.00	Low
4/29/2021	Oppenheimer	Boost Target	Outperform	$460.00 ➝ $480.00	Low
4/29/2021	Mizuho	Boost Target	Buy	$462.00 ➝ $480.00	Medium
1/6/2021	Argus	Boost Target	Buy	$430.00 ➝ $450.00	N/A
1/4/2021	Royal Bank of Canada	Upgrade	Sector Perform ➝ Outperform	$429.00 ➝ $479.00	N/A
11/30/2020	SVB Leerink	Lower Target	Sell ➝ Outperform	$505.00 ➝ $500.00	High
11/4/2020	Smith Barney Citigroup	Boost Target		$469.00 ➝ $496.00	Low
11/4/2020	Credit Suisse Group	Boost Target	Outperform	$423.00 ➝ $465.00	Low
11/4/2020	Oppenheimer	Boost Target	Outperform	$440.00 ➝ $460.00	Low
11/4/2020	Stephens	Boost Target	Overweight	$450.00 ➝ $490.00	Low
10/13/2020	Truist Financial	Boost Target		$455.00 ➝ $475.00	Low
10/1/2020	Sanford C. Bernstein	Initiated Coverage	Market Perform	$459.00	Medium
10/1/2020	Piper Sandler	Boost Target	Overweight	$473.00 ➝ $495.00	Low
9/10/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$397.00 ➝ $431.00	High
8/18/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$394.00 ➝ $452.00	Low
8/17/2020	Royal Bank of Canada	Boost Target	Sector Perform	$388.00 ➝ $420.00	Low
8/10/2020	Stephens	Boost Target	Overweight	$433.00 ➝ $450.00	Low
8/7/2020	Mizuho	Boost Target	Buy	$420.00 ➝ $462.00	High
8/6/2020	Credit Suisse Group	Reiterated Rating	Buy		Low
8/6/2020	Piper Sandler	Boost Target	Overweight	$442.00 ➝ $473.00	Medium
8/6/2020	Oppenheimer	Boost Target	Outperform	$425.00 ➝ $440.00	Low
8/6/2020	SVB Leerink	Boost Target	Outperform	$465.00 ➝ $496.00	Medium
7/1/2020	SVB Leerink	Initiated Coverage	Outperform	$465.00	Low
6/18/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Hold	$421.00 ➝ $397.00	Low
6/17/2020	Cantor Fitzgerald	Boost Target		$405.00 ➝ $410.00	Medium
6/16/2020	Cowen	Reiterated Rating	Outperform ➝ Market Perform	$410.00	Medium
6/5/2020	The Goldman Sachs Group	Initiated Coverage	Buy	$510.00	Medium
5/21/2020	SunTrust Banks	Boost Target	Hold	$400.00 ➝ $440.00	Low
5/4/2020	Mizuho	Boost Target	Buy	$405.00 ➝ $420.00	Low
4/30/2020	CSFB	Boost Target	Outperform	$400.00 ➝ $423.00	Medium
4/30/2020	Credit Suisse Group	Boost Target	Outperform	$400.00 ➝ $423.00	High
4/30/2020	Citigroup	Boost Target	Buy	$424.00 ➝ $435.00	Medium
4/30/2020	Morgan Stanley	Boost Target	Overweight	$375.00 ➝ $500.00	Medium
4/30/2020	Oppenheimer	Boost Target	Outperform	$400.00 ➝ $425.00	Medium
4/13/2020	Morgan Stanley	Boost Target	Overweight	$343.00 ➝ $375.00	Medium
3/29/2020	Barclays	Reiterated Rating	Buy		High
3/27/2020	Morgan Stanley	Lower Target	Overweight	$460.00 ➝ $343.00	Medium
2/19/2020	Royal Bank of Canada	Reiterated Rating	Hold	$370.00	Low
2/18/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$363.00 ➝ $433.00	Medium
2/14/2020	Mizuho	Reiterated Rating	Buy	$405.00	N/A
2/6/2020	Morgan Stanley	Boost Target	Overweight	$457.00 ➝ $460.00	Low
2/6/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$319.00 ➝ $363.00	Medium
2/6/2020	Mizuho	Boost Target	Buy	$400.00 ➝ $405.00	Medium
2/5/2020	Cantor Fitzgerald	Boost Target	Overweight	$345.00 ➝ $400.00	Low
1/27/2020	The Goldman Sachs Group	Reiterated Rating	Buy	$425.00	Medium
1/23/2020	UBS Group	Boost Target	Neutral	$321.00 ➝ $406.00	Low
1/8/2020	Credit Suisse Group	Boost Target	Outperform	$378.00 ➝ $400.00	High
1/3/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$437.00 ➝ $448.00	Medium
1/3/2020	The Goldman Sachs Group	Reiterated Rating	Buy ➝ Buy	$425.00 ➝ $425.00	Medium
12/20/2019	JPMorgan Chase & Co.	Boost Target	Overweight	$322.00 ➝ $437.00	Low
12/17/2019	SunTrust Banks	Reiterated Rating	Hold	$370.00	Low
12/11/2019	Wells Fargo & Company	Reiterated Rating	Overweight	$338.00 ➝ $400.00	Low
12/6/2019	Barclays	Boost Target	Overweight	$327.00 ➝ $358.00	Low
11/20/2019	Argus	Boost Target	Buy	$370.00	Low
11/18/2019	Morgan Stanley	Reiterated Rating	Buy	$337.00 ➝ $360.00	Low
11/15/2019	SunTrust Banks	Boost Target	Positive ➝ Hold	$350.00	High
11/7/2019	SunTrust Banks	Boost Target	Hold	$335.00	High
10/17/2019	Mizuho	Initiated Coverage	Buy	$316.00	High
9/30/2019	BMO Capital Markets	Downgrade	Outperform ➝ Market Perform	$345.00 ➝ $290.00	Low
9/26/2019	Morgan Stanley	Lower Target	Overweight	$342.00 ➝ $337.00	High
9/12/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$300.00	High
8/23/2019	Morgan Stanley	Boost Target	Overweight	$315.00 ➝ $342.00	Medium
8/12/2019	Cantor Fitzgerald	Upgrade	Neutral ➝ Overweight	$300.00 ➝ $345.00	Medium
8/1/2019	JPMorgan Chase & Co.	Boost Target	Overweight	$288.00 ➝ $322.00	Low
8/1/2019	Piper Jaffray Companies	Boost Target	Overweight	$315.00 ➝ $341.00	Low
8/1/2019	UBS Group	Boost Target	Neutral	$266.00 ➝ $317.00	Low
8/1/2019	SunTrust Banks	Boost Target	Hold	$340.00	Low
7/12/2019	Morgan Stanley	Lower Target	Overweight	$331.00 ➝ $315.00	High
5/2/2019	SunTrust Banks	Lower Target		$300.00	Low
5/2/2019	Oppenheimer	Lower Target	Outperform	$373.00 ➝ $350.00	Low
5/2/2019	Morgan Stanley	Set Target	Buy	$331.00	Low
5/2/2019	Credit Suisse Group	Lower Target	Outperform	$352.00 ➝ $315.00	Low
5/2/2019	Citigroup	Lower Target	Buy ➝ Buy	$362.00 ➝ $302.00	Low
4/23/2019	UBS Group	Initiated Coverage	Neutral ➝ Neutral	$266.00	Medium
4/17/2019	Barclays	Lower Target	Overweight ➝ Overweight	$351.00 ➝ $327.00	Low
2/7/2019	Citigroup	Lower Target	Buy ➝ Buy	$397.00 ➝ $362.00	Low
2/7/2019	Credit Suisse Group	Lower Target	Outperform	$390.00 ➝ $352.00	Low
1/14/2019	Stephens	Initiated Coverage	Overweight	$336.00	Low
1/11/2019	Cowen	Upgrade	Market Perform ➝ Outperform	$275.02	High
1/6/2019	Barclays	Reiterated Rating	Buy	$351.00	Low
1/2/2019	Cantor Fitzgerald	Reiterated Rating	Hold	$325.00	High
12/20/2018	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$283.00	Medium
11/8/2018	Morgan Stanley	Boost Target	Overweight ➝ Buy	$400.00 ➝ $418.00	Low
11/8/2018	BMO Capital Markets	Set Target	Buy	$390.00	Low
11/8/2018	Royal Bank of Canada	Boost Target	Sector Perform ➝ Sector Perform	$318.00 ➝ $349.00	Low
11/8/2018	Credit Suisse Group	Boost Target	Outperform ➝ Outperform	$370.00 ➝ $390.00	Low
11/8/2018	Bank of America	Boost Target	Buy	$400.00 ➝ $415.00	Medium
11/8/2018	Jefferies Financial Group	Boost Target	Buy ➝ Buy	$388.00 ➝ $410.00	High
9/19/2018	SunTrust Banks	Boost Target	Hold	$380.00	Low
9/17/2018	Cowen	Initiated Coverage	Market Perform	$372.00	Low
9/13/2018	Barclays	Initiated Coverage	Overweight ➝ Overweight	$370.00	Medium
9/4/2018	Credit Suisse Group	Boost Target	Outperform	$350.00 ➝ $370.00	Low
9/4/2018	Argus	Boost Target	Buy	$375.00	Low
8/24/2018	Piper Jaffray Companies	Boost Target	Overweight	$355.00 ➝ $380.00	Low
8/2/2018	SunTrust Banks	Reiterated Rating	Hold	$350.00	Low
8/2/2018	Piper Jaffray Companies	Reiterated Rating	Buy	$355.00	Low
8/2/2018	Bank of America	Boost Target	Buy ➝ Buy	$338.00 ➝ $375.00	Low
8/2/2018	Morgan Stanley	Boost Target	Overweight ➝ Overweight	$362.00 ➝ $365.00	Low
8/2/2018	Jefferies Financial Group	Boost Target	Buy ➝ Buy	$356.00 ➝ $372.00	Low
8/2/2018	Royal Bank of Canada	Reiterated Rating	Hold	$318.00	Low
7/12/2018	Morgan Stanley	Initiated Coverage	Overweight	$362.00	Low
7/6/2018	Piper Jaffray Companies	Boost Target	Overweight	$326.00 ➝ $350.00	Medium
6/25/2018	BMO Capital Markets	Boost Target	Outperform ➝ Outperform	$328.00 ➝ $355.00	Low
6/1/2018	Citigroup	Reiterated Rating	Buy ➝ Buy	$280.00 ➝ $340.00	Low

(Data available from 5/28/2018 forward)

News Sentiment Rating

0.64 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

32 very positive mentions
27 positive mentions
3 negative mentions
1 very negative mentions

Mentions as of

10/30/2022

22 very positive mentions
15 positive mentions
3 negative mentions
1 very negative mentions

Mentions as of

11/29/2022

18 very positive mentions
13 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

12/29/2022

14 very positive mentions
16 positive mentions
3 negative mentions
1 very negative mentions

Mentions as of

1/28/2023

26 very positive mentions
9 positive mentions
4 negative mentions
1 very negative mentions

Mentions as of

2/27/2023

23 very positive mentions
7 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

3/29/2023

34 very positive mentions
36 positive mentions
5 negative mentions
0 very negative mentions

Mentions as of

4/28/2023

19 very positive mentions
32 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

5/28/2023

Current Sentiment

Recent Stories by Sentiment

Very Negative

No very negative mentions tracked during this time.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Today's Range

Now: $496.60

$495.27

$503.27

50 Day Range

MA: $513.07

$483.41

$535.96

52 Week Range

Now: $496.60

$418.70

$571.30

Volume

648,843 shs

Average Volume

703,121 shs

Market Capitalization

$62.05 billion

P/E Ratio

20.17

Dividend Yield

0.71%

Beta

0.72

Frequently Asked Questions

What sell-side analysts currently cover shares of Humana?: The following sell-side analysts have issued reports on Humana in the last twelve months: Cantor Fitzgerald, Cowen Inc, Cowen Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Loop Capital, Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Royal Bank of Canada, Stephens, StockNews.com, SVB Leerink LLC, SVB Securities, The Goldman Sachs Group, Inc., TheStreet, Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for HUM.
What is the current price target for Humana?: 18 Wall Street analysts have set twelve-month price targets for Humana in the last year. Their average twelve-month price target is $602.44, suggesting a possible upside of 21.3%. The Goldman Sachs Group, Inc. has the highest price target set, predicting HUM will reach $652.00 in the next twelve months. Loop Capital has the lowest price target set, forecasting a price of $510.00 for Humana in the next year.
View the latest price targets for HUM.
What is the current consensus analyst rating for Humana?: Humana currently has 1 hold rating and 14 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HUM will outperform the market and that investors should add to their positions of Humana.
View the latest ratings for HUM.
What other companies compete with Humana?: Other companies that are similar to Humana include Centene, Elevance Health, Molina Healthcare, Becton, Dickinson and and GSK. Learn More about companies similar to Humana.
How do I contact Humana's investor relations team?: Humana's physical mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider's listed phone number is (502) 580-1000 and its investor relations email address is [email protected]. The official website for Humana is www.humana.com. Learn More about contacing Humana investor relations.

Humana - HUM Stock Price Target and Predictions

Analyst Price Target for HUM

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.64 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Humana?

What is the current price target for Humana?

What is the current consensus analyst rating for Humana?

What other companies compete with Humana?

How do I contact Humana's investor relations team?